PURPOSE: Survey data indicate that continuous electroencephalography (EEG) (CEEG) monitoring is used with increasing frequency to identify electrographic seizures in critically ill children, but studies of current CEEG practice have not been conducted. We aimed to describe the clinical utilization of CEEG in critically ill children at tertiary care hospitals with a particular focus on variables essential for designing feasible prospective multicenter studies evaluating the impact of electrographic seizures on outcome. METHODS: Eleven North American centers retrospectively enrolled 550 consecutive critically ill children who underwent CEEG. We collected data regarding subject characteristics, CEEG indications, and CEEG findings. KEY FINDINGS: CEEG indications were encephalopathy with possible seizures in 67% of subjects, event characterization in 38% of subjects, and management of refractory status epilepticus in 11% of subjects. CEEG was initiated outside routine work hours in 47% of subjects. CEEG duration was <12 h in 16%, 12-24 h in 34%, and >24 h in 48%. Substantial variability existed among sites in CEEG indications and neurologic diagnoses, yet within each acute neurologic diagnosis category a similar proportion of subjects at each site had electrographic seizures. Electrographic seizure characteristics including distribution and duration varied across sites and neurologic diagnoses. SIGNIFICANCE: These data provide a systematic assessment of recent CEEG use in critically ill children and indicate variability in practice. The results suggest that multicenter studies are feasible if CEEG monitoring pathways can be standardized. However, the data also indicate that electrographic seizure variability must be considered when designing studies that address the impact of electrographic seizures on outcome. Wiley Periodicals, Inc.
PURPOSE: Survey data indicate that continuous electroencephalography (EEG) (CEEG) monitoring is used with increasing frequency to identify electrographic seizures in critically ill children, but studies of current CEEG practice have not been conducted. We aimed to describe the clinical utilization of CEEG in critically ill children at tertiary care hospitals with a particular focus on variables essential for designing feasible prospective multicenter studies evaluating the impact of electrographic seizures on outcome. METHODS: Eleven North American centers retrospectively enrolled 550 consecutive critically ill children who underwent CEEG. We collected data regarding subject characteristics, CEEG indications, and CEEG findings. KEY FINDINGS:CEEG indications were encephalopathy with possible seizures in 67% of subjects, event characterization in 38% of subjects, and management of refractory status epilepticus in 11% of subjects. CEEG was initiated outside routine work hours in 47% of subjects. CEEG duration was <12 h in 16%, 12-24 h in 34%, and >24 h in 48%. Substantial variability existed among sites in CEEG indications and neurologic diagnoses, yet within each acute neurologic diagnosis category a similar proportion of subjects at each site had electrographic seizures. Electrographic seizure characteristics including distribution and duration varied across sites and neurologic diagnoses. SIGNIFICANCE: These data provide a systematic assessment of recent CEEG use in critically ill children and indicate variability in practice. The results suggest that multicenter studies are feasible if CEEG monitoring pathways can be standardized. However, the data also indicate that electrographic seizure variability must be considered when designing studies that address the impact of electrographic seizures on outcome. Wiley Periodicals, Inc.
Authors: Alexis A Topjian; Ana M Gutierrez-Colina; Sarah M Sanchez; Robert A Berg; Stuart H Friess; Dennis J Dlugos; Nicholas S Abend Journal: Crit Care Med Date: 2013-01 Impact factor: 7.598
Authors: Nicholas S Abend; Ana Gutierrez-Colina; Huaqing Zhao; Rong Guo; Eric Marsh; Robert R Clancy; Dennis J Dlugos Journal: J Clin Neurophysiol Date: 2011-02 Impact factor: 2.177
Authors: Hansel M Greiner; Katherine Holland; James L Leach; Paul S Horn; Andrew D Hershey; Douglas F Rose Journal: Pediatrics Date: 2012-02-13 Impact factor: 7.124
Authors: Gretchen M Brophy; Rodney Bell; Jan Claassen; Brian Alldredge; Thomas P Bleck; Tracy Glauser; Suzette M Laroche; James J Riviello; Lori Shutter; Michael R Sperling; David M Treiman; Paul M Vespa Journal: Neurocrit Care Date: 2012-08 Impact factor: 3.210
Authors: Nicholas S Abend; Kevin E Chapman; William B Gallentine; Joshua Goldstein; Ann E Hyslop; Tobias Loddenkemper; Kendall B Nash; James J Riviello; Cecil D Hahn Journal: Curr Neurol Neurosci Rep Date: 2013-03 Impact factor: 5.081
Authors: Lawrence R Wechsler; Jack W Tsao; Steven R Levine; Rebecca J Swain-Eng; Robert J Adams; Bart M Demaerschalk; David C Hess; Elena Moro; Lee H Schwamm; Steve Steffensen; Barney J Stern; Steven J Zuckerman; Pratik Bhattacharya; Larry E Davis; Ilana R Yurkiewicz; Aimee L Alphonso Journal: Neurology Date: 2013-02-12 Impact factor: 9.910
Authors: John M Schreiber; Tesfaye Zelleke; William D Gaillard; Himanshu Kaulas; Nathan Dean; Jessica L Carpenter Journal: Neurocrit Care Date: 2012-08 Impact factor: 3.210
Authors: Fenella J Kirkham; Angela M Wade; Fiona McElduff; Stewart G Boyd; Robert C Tasker; Melinda Edwards; Brian G R Neville; Norbert Peshu; Charles R J C Newton Journal: Intensive Care Med Date: 2012-04-11 Impact factor: 17.440
Authors: Iván Sánchez Fernández; Nicholas S Abend; Daniel H Arndt; Jessica L Carpenter; Kevin E Chapman; Karen M Cornett; Dennis J Dlugos; William B Gallentine; Christopher C Giza; Joshua L Goldstein; Cecil D Hahn; Jason T Lerner; Joyce H Matsumoto; Kristin McBain; Kendall B Nash; Eric Payne; Sarah M Sánchez; Korwyn Williams; Tobias Loddenkemper Journal: J Pediatr Date: 2013-10-22 Impact factor: 4.406
Authors: Susan T Herman; Nicholas S Abend; Thomas P Bleck; Kevin E Chapman; Frank W Drislane; Ronald G Emerson; Elizabeth E Gerard; Cecil D Hahn; Aatif M Husain; Peter W Kaplan; Suzette M LaRoche; Marc R Nuwer; Mark Quigg; James J Riviello; Sarah E Schmitt; Liberty A Simmons; Tammy N Tsuchida; Lawrence J Hirsch Journal: J Clin Neurophysiol Date: 2015-04 Impact factor: 2.177
Authors: Susan T Herman; Nicholas S Abend; Thomas P Bleck; Kevin E Chapman; Frank W Drislane; Ronald G Emerson; Elizabeth E Gerard; Cecil D Hahn; Aatif M Husain; Peter W Kaplan; Suzette M LaRoche; Marc R Nuwer; Mark Quigg; James J Riviello; Sarah E Schmitt; Liberty A Simmons; Tammy N Tsuchida; Lawrence J Hirsch Journal: J Clin Neurophysiol Date: 2015-04 Impact factor: 2.177
Authors: Amy Yang; Daniel H Arndt; Robert A Berg; Jessica L Carpenter; Kevin E Chapman; Dennis J Dlugos; William B Gallentine; Christopher C Giza; Joshua L Goldstein; Cecil D Hahn; Jason T Lerner; Tobias Loddenkemper; Joyce H Matsumoto; Kendall B Nash; Eric T Payne; Iván Sánchez Fernández; Justine Shults; Alexis A Topjian; Korwyn Williams; Courtney J Wusthoff; Nicholas S Abend Journal: Seizure Date: 2014-10-05 Impact factor: 3.184
Authors: Alexis A Topjian; Michael Fry; Abbas F Jawad; Susan T Herman; Vinay M Nadkarni; Rebecca Ichord; Robert A Berg; Dennis J Dlugos; Nicholas S Abend Journal: Pediatr Crit Care Med Date: 2015-06 Impact factor: 3.624
Authors: France W Fung; Jiaxin Fan; Lisa Vala; Marin Jacobwitz; Darshana S Parikh; Maureen Donnelly; Alexis A Topjian; Rui Xiao; Nicholas S Abend Journal: Neurology Date: 2020-07-20 Impact factor: 9.910
Authors: France W Fung; Jiaxin Fan; Darshana S Parikh; Lisa Vala; Maureen Donnelly; Marin Jacobwitz; Alexis A Topjian; Rui Xiao; Nicholas S Abend Journal: J Clin Neurophysiol Date: 2022-04-20 Impact factor: 2.590
Authors: Jian Hu; France W Fung; Marin Jacobwitz; Darshana S Parikh; Lisa Vala; Maureen Donnelly; Alexis A Topjian; Nicholas S Abend; Rui Xiao Journal: Seizure Date: 2021-03-04 Impact factor: 3.184
Authors: Zubeda Sheikh; Olga Selioutski; Olga Taraschenko; Emily J Gilmore; M Brandon Westover; Adam B Cohen Journal: J Clin Neurophysiol Date: 2022-01-20 Impact factor: 2.590